Prem Singh Biography and Net Worth

Mr. Singh has served as our Senior Vice President, Global Operations since January 2023. Previously, he served as our Group Vice President, Head of Global Supply Chain Operations from December 2021 through December 2022 where he provided supply chain leadership to ensure component availability and improved supply chain efficiency to increase capacity. Prior to joining Insulet, Mr. Singh served as Vice President of Operations and Quality for the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific Inc. where he played a leadership role in Operations and Quality. Previously, he spent 18 years at General Electric in various roles and his responsibilities increased within global operations and end-to-end supply chain. He also served as General Manager of Global Supply Chain Operations for GE Inspection Technologies. Mr. Singh earned a Bachelor of Science in Finance and Marketing from Boston College and he is a Certified Six Sigma Master Black Belt.

What is Prem Singh's net worth?: The estimated net worth of Prem Singh is at least $670,078.08 as of September 19th, 2023. Mr. Singh owns 4,032 shares of Insulet stock worth more than $670,078 as of April 27th. This net worth evaluation does not reflect any other assets that Mr. Singh may own. Learn More about Prem Singh's net worth.
How do I contact Prem Singh?: The corporate mailing address for Mr. Singh and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on Prem Singh's contact information.
Has Prem Singh been buying or selling shares of Insulet?: Prem Singh has not been actively trading shares of Insulet within the last three months. Most recently, on Tuesday, September 19th, Prem Singh bought 1 shares of Insulet stock. The stock was acquired at an average cost of $168.92 per share, with a total value of $168.92. Following the completion of the transaction, the senior vice president now directly owns 4,032 shares of the company's stock, valued at $681,085.44. Learn More on Prem Singh's trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, Insulet insiders bought shares 2 times. They purchased a total of 5,551 shares worth more than $1,006,994.42. In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 48,672 shares worth more than $9,836,499.00. The most recent insider tranaction occured on February, 28th when Director Shacey Petrovic sold 11,609 shares worth more than $1,891,338.28. Insiders at Insulet own 0.9% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 2/28/2024.

Prem Singh Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/19/2023	Buy	1	$168.92	$168.92	4,032

Prem Singh Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $166.19

$163.00

$168.38

50 Day Range

MA: $171.51

$163.25

$197.14

2 Week Range

Now: $166.19

$125.82

$335.91

Volume

636,152 shs

Average Volume

862,355 shs

Market Capitalization

$11.64 billion

P/E Ratio

57.11

Dividend Yield

N/A

Beta

0.98

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>